ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print

NEC taps AI for faster path to coronavirus vaccine

Japanese group conducts genetic analysis, now seeks partners for trials

NEC has joined the ranks of companies searching for a coronavirus vaccine.   © Reuters

TOKYO -- Japanese technology group NEC has used artificial intelligence to conduct a faster genetic decoding of the novel coronavirus, aiming to accelerate the development of a vaccine to quell the pandemic.

NEC completed its analysis of the genetic structure in a month, far less time than typically needed to decode a virus.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more